Stereotaxic radiotherapy of primary extracranial tumors

被引：2
作者：
Giraud, P. [7 ]
Lerouge, D. [1 ]
Latorzeff, I [2 ]
Mirabel, X. [3 ]
Dohan, A. [4 ]
Mordant, P. [5 ]
de Longchamps, N. Barry [6 ]
机构：
[1] Ctr Francois Baclesse, Dept Radiotherapie, Ave Gen Harris, F-14076 Caen, France
[2] Clin Pasteur, Dept Radiotherapie Oncol, Batiment Atrium,1 Rue Petite Vitesse, F-37300 Toulouse, France
[3] Ctr Oscar Lambret, Dept Radiotherapie, 3 Rue Freder Combemale, F-59000 Lille, France
[4] Univ Paris, Hop Cochin, AP HP, Serv Radiol A,Unite Radiol Abdominopelvienne & In, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[5] Univ Paris, Hop Bichat, AP HP, Unite Inserm U1152,Serv Chirurg Vasc Thorac & Tra, 46 Rue Henri Huchard, F-75018 Paris, France
[6] Hop Cochin, Inst Necker Enfants Malad, Serv Urol, Inserm U1151 Equipe 4, 27 Rue Faubourg St Jacques, F-75014 Paris, France
[7] Univ Paris, Hop Europeen Georges Pompidou, AP HP, Serv Oncol Radiotherapie, 20 Rue Leblanc, F-75015 Paris, France
来源：
CANCER RADIOTHERAPIE | 2020年 / 24卷 / 6-7期
关键词：
Stereotactic radiotherapy; Minimally invasive surgery; Interventional radiology; Lung cancer; Prostate cancer; Hepatic cancer; BODY RADIATION-THERAPY; CELL LUNG-CANCER; QUALITY-OF-LIFE; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; RADICAL PROSTATECTOMY; FOLLOW-UP; PHASE-II; OUTCOMES; GUIDELINES;
D O I：
10.1016/j.canrad.2020.06.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Stereotactic radiotherapy is a fundamental change from the conventional fractionated radiotherapy and represents a new therapeutic indication. Stereotactic radiotherapy is now a standard of care for inoperable patients or patients who refuse surgery. The results are encouraging with local control and survival rates very high in selected populations. The rate of late toxicity remains acceptable. Good tolerability makes it appropriate even for elderly and frail patients. In these fragile patients or in certain specific clinical situations, different surgical, radiotherapy or interventional radiology attitudes can be discussed on a case-by-case basis. These situations are considered in this article for the pulmonary, hepatic and prostatic localizations. (C) 2020 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：513 / 522
页数：10
相关论文
共 50 条
  • [21] Radiochromic film for individual patient QA in extracranial stereotactic lung radiotherapy
    Kron, T.
    Clements, N.
    Aarons, Y.
    Dunn, L.
    Chesson, B.
    Miller, J.
    Roozen, K.
    Ball, D.
    [J]. RADIATION MEASUREMENTS, 2011, 46 (12) : 1920 - 1923
  • [22] Stereotactic Body Radiotherapy for Primary Prostate Cancer
    Kothari, Gargi
    Loblaw, Andrew
    Tree, Alison C.
    van As, Nicholas J.
    Moghanaki, Drew
    Lo, Simon S.
    Ost, Piet
    Siva, Shankar
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [23] Spine Oncology - Primary Spine Tumors
    Dea, Nicolas
    Gokaslan, Ziya
    Choi, David
    Fisher, Charles
    [J]. NEUROSURGERY, 2017, 80 (03) : S124 - S130
  • [24] Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients
    Yamashita, Hideomi
    Onishi, Hiroshi
    Matsumoto, Yasuo
    Murakami, Naoya
    Matsuo, Yukinori
    Nomiya, Takuma
    Nakagawa, Keiichi
    [J]. RADIATION ONCOLOGY, 2014, 9
  • [25] Stereotactic body radiotherapy treatment of extracranial metastases
    Salama, Joseph K.
    Kirkpatrick, John P.
    Yin, Fang-Fang
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (11) : 654 - 665
  • [26] Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer A Decision Analysis
    Parikh, Ravi
    Sher, David J.
    [J]. CANCER, 2012, 118 (01) : 258 - 267
  • [27] Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors
    Atalar, Banu
    Mustafayev, Teuta Zoto
    Sio, Terence T.
    Sahin, Bilgehan
    Gungor, Gorkem
    Aydin, Gokhan
    Yapici, Bulent
    Ozyar, Enis
    [J]. RADIOLOGY AND ONCOLOGY, 2020, 54 (04) : 480 - 487
  • [28] Organization and risk management in stereotaxic body radiotherapy at the treatment station
    Bouvet, C.
    Bertin, K.
    Lafond, C.
    Williaume, D.
    de Crevoisier, R.
    Leroy, E.
    [J]. CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 532 - 536
  • [29] Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer
    Mutsaers, Adam
    Greenspoon, Jeffrey
    Walker-Dilks, Cindy
    Swaminath, Anand
    [J]. RADIATION ONCOLOGY, 2017, 12
  • [30] Extracranial doses in stereotactic and conventional radiotherapy for pituitary adenomas
    Ram, Thomas Samuel
    Ravindran, Paul B.
    Viswanathan, Faith R.
    Viswanathan, Perungulam Narayan
    Pavamani, Simon P.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2006, 7 (02): : 96 - 100
12345